Showing 3131-3140 of 21432 results for "".
- Heart Transplant Patients Show Increased Skin Cancer Incidence: Meta-Analysishttps://reachmd.com/news/heart-transplant-patients-show-increased-skin-cancer-incidence-meta-analysis/2470902/Heart transplant (HTx) recipients face a 16% overall risk of developing skin cancer, with squamous and basal cell carcinomas being the most common forms, a new meta-analysis indicated. "Studies have shown that patients who undergo HTx are at an increased risk for developing skin cancer," t
- Key Mortality Factors in ICU Sepsis Patients Exploredhttps://reachmd.com/news/key-mortality-factors-icu-sepsis-patients-explored/2470895/What's New A recent study delves into the mortality rates of ICU patients with sepsis and septic shock, highlighting critical predictors such as organ dysfunction, age, and APACHE II scores. Significance This study identifies key predictors of mortal
- Evaluating Hospital Admission Necessity for Elderly Patients with Mild Brain Injurieshttps://reachmd.com/news/evaluating-hospital-admission-necessity-elderly-patients-mild-brain-injuries/2470893/What's New A recent study delves into the necessity of hospital admissions for elderly patients experiencing mild traumatic brain injuries (mTBI) with traumatic intracranial hemorrhage (tICH), challenging the current medical protocols. Significance T
- No Increased Thyroid Cancer Risk from GLP1-RA Usehttps://reachmd.com/news/no-increased-thyroid-cancer-risk-glp1-ra-use/2470892/What's New Research from an international cohort study provides reassurance to patients using GLP1-RAs, showing no increased risk of thyroid cancer. Significance This finding is crucial for endocrinologists and primary care providers as it highlights
- Illuminate PRP Adds Industry Veteran Redmond as CCOhttps://reachmd.com/news/illuminate-prp-adds-industry-veteran-redmond-as-cco/2473726/Industry veteran Jennifer Redmond, MBA, joined Illuminate PRP as Chief Commercial Officer, the company announced. “Jennifer brings a wealth of experience in sales and marketing within the aesthetics and pharmaceutical industries, along with strong leadership and a commitment to driving pos
- Illuminate PRP Adds Industry Veteran Redmond as CCOhttps://reachmd.com/news/illuminate-prp-adds-industry-veteran-redmond-cco/2470885/Industry veteran Jennifer Redmond, MBA, joined Illuminate PRP as Chief Commercial Officer, the company announced. “Jennifer brings a wealth of experience in sales and marketing within the aesthetics and pharmaceutical industries, along with strong leadership and a commitment to driving pos
- Identifying Genetic Keys to Osteoarthritishttps://reachmd.com/news/identifying-genetic-keys-osteoarthritis/2470879/What's New Researchers have identified 13 genes that significantly increase the risk of developing osteoarthritis, potentially opening paths to targeted therapies. Significance Understanding genetic factors in osteoarthritis is essential for developi
- New Data Reveals GLP-1 Medications Impact on Medical Aesthetics Growthhttps://reachmd.com/news/new-data-reveals-glp-1-medications-impact-on-medical-aesthetics-growth/2473724/Guidepoint Qsight revealed new insights Thursday on the state of the $17.5 billion medical aesthetics industry, which was up 2% in 2024. The findings highlight how the integration of glucagon-like peptide-1 (GLP-1) medications for weight loss is reshaping the aesthetics market. GLP-1 medic
- AI and the Future of Glaucoma Treatment through RIPK3 Inhibitionhttps://reachmd.com/news/ai-and-future-glaucoma-treatment-through-ripk3-inhibition/2470881/What's New Researchers have utilized AI to discover RIPK3 inhibitors, offering new hope for glaucoma treatments. Significance Glaucoma affects millions worldwide, with AI offering a potential breakthrough in identifying effective treatments.
- AI Techniques Refine IVF Follicle Monitoring for Improved Outcomeshttps://reachmd.com/news/ai-techniques-refine-ivf-follicle-monitoring-improved-outcomes/2470876/What's New Researchers from Imperial College London have utilized explainable AI to refine the monitoring of follicle sizes in IVF treatments, yielding improved outcomes for patients struggling with infertility. Significance A novel application of Ex